loadpatents
name:-0.043337106704712
name:-0.022390127182007
name:-0.012825012207031
Hecht; Sidney Patent Filings

Hecht; Sidney

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hecht; Sidney.The latest application filed is for "dna-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells overexpressing her2".

Company Profile
15.33.48
  • Hecht; Sidney - Phoenix AZ
  • HECHT; Sidney - Scottsdale AZ
  • Hecht; Sidney - Charlottesville VA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ribosome-mediated incorporation of peptides and peptidomimetics
Grant 11,434,492 - Hecht , et al. September 6, 2
2022-09-06
Dna-affibody-drug Nanoparticles For Inhibiting The Metastasis Of Cancer Cells Overexpressing Her2
App 20220265838 - Hecht; Sidney ;   et al.
2022-08-25
Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
Grant 11,390,605 - Hecht , et al. July 19, 2
2022-07-19
Methods of rational nicotine hapten design and uses thereof
Grant 11,357,848 - Chang , et al. June 14, 2
2022-06-14
Phenothiazine Analogues As Mitochondrial Therapeutic Agents
App 20220081404 - HECHT; Sidney ;   et al.
2022-03-17
Compositions And Methods For Detecting Viral Nucleic Acids
App 20210403983 - Chen; Shengxi ;   et al.
2021-12-30
Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting
Grant 11,203,583 - Chevalier , et al. December 21, 2
2021-12-21
Therapeutic Compounds
App 20210276979 - HECHT; Sidney ;   et al.
2021-09-09
Substituted phenothiazines as mitochondrial agents
Grant 11,034,662 - Hecht , et al. June 15, 2
2021-06-15
Therapeutic Compounds
App 20200407333 - HECHT; Sidney ;   et al.
2020-12-31
Ribosome-Mediated Incorporation of Peptides and Peptidomimetics
App 20200370057 - Hecht; Sidney ;   et al.
2020-11-26
Engineered Bacterial Ribosome Compositions And Methods
App 20200299333 - Hecht; Sidney ;   et al.
2020-09-24
Therapeutic compounds
Grant 10,745,366 - Hecht , et al. A
2020-08-18
Ribosome-mediated incorporation of peptides and peptidomimetics
Grant 10,745,705 - Hecht , et al. A
2020-08-18
Prodrug And Profluorescent Compounds For Selective Mitochondrial Imaging And Therapeutic Targeting
App 20200247775 - Kind Code
2020-08-06
Phenothiazine Analogues As Mitochondrial Therapeutic Agents
App 20200115355 - HECHT; Sidney ;   et al.
2020-04-16
Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting
Grant 10,604,501 - Chevalier , et al.
2020-03-31
Peptide-DNA chimeras for treatment of HER overexpressing cancers
Grant 10,532,109 - Chen , et al. Ja
2020-01-14
Substituted phenothiazines as mitochondrial agents
Grant 10,472,340 - Hecht , et al. Nov
2019-11-12
Peptide-dna Chimeras For Treatment Of Her Overexpressing Cancers
App 20190282706 - CHEN; Shengxi ;   et al.
2019-09-19
Therapeutic compounds
Grant 10,364,227 - Hecht , et al.
2019-07-30
Therapeutic Compounds
App 20190185441 - HECHT; Sidney ;   et al.
2019-06-20
Compositions And Methods For Detecting Viral Nucleic Acids
App 20180371526 - Chen; Shengxi ;   et al.
2018-12-27
Therapeutic Compounds
App 20180319751 - HECHT; Sidney ;   et al.
2018-11-08
Saccharide conjugates
Grant 10,046,068 - Hecht , et al. August 14, 2
2018-08-14
Methods Of Rational Nicotine Hapten Design And Uses Thereof
App 20180125969 - Chang; Yung ;   et al.
2018-05-10
Multifunctional radical quenchers
Grant 9,957,214 - Madathil , et al. May 1, 2
2018-05-01
Sugar-linker-drug conjugates
Grant 9,919,055 - Hecht , et al. March 20, 2
2018-03-20
Phenothiazine Analogues As Mitochondrial Therapeutic Agents
App 20180065941 - HECHT; Sidney ;   et al.
2018-03-08
Methods of rational nicotine hapten design and uses thereof
Grant 9,884,114 - Chang , et al. February 6, 2
2018-02-06
Ribosome-mediated Incorporation Of Peptides And Peptidomimetics
App 20180002709 - HECHT; Sidney ;   et al.
2018-01-04
Carbohydrate-mediated tumor targeting
Grant 9,624,255 - Hecht , et al. April 18, 2
2017-04-18
Methods Of Rational Nicotine Hapten Design And Uses Thereof
App 20160375131 - Chang; Yung ;   et al.
2016-12-29
1H-pyrrolo [2, 3 -B] pyridine derivatives and their use as radical quenchers
Grant 9,440,967 - Hecht , et al. September 13, 2
2016-09-13
Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
Grant 9,388,163 - Hecht , et al. July 12, 2
2016-07-12
Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
Grant 9,334,250 - Chowdhury , et al. May 10, 2
2016-05-10
Sugar-linker-drug Conjugates
App 20160045611 - Hecht; Sidney ;   et al.
2016-02-18
Saccharide Conjugates
App 20160038615 - Hecht; Sidney ;   et al.
2016-02-11
Multifunctional Radical Quenchers
App 20150274628 - Madathil; Manikandadas Mathilakathu ;   et al.
2015-10-01
Multifunctional Radical Quenchers For The Treatment Of Mitochondrial Dysfunction
App 20150266851 - Hecht; Sidney ;   et al.
2015-09-24
Multifunctional Radical Quenchers for the Treatment of Mitochondrial Dysfunction
App 20150259309 - Chowdhury; Sandipan Roy ;   et al.
2015-09-17
Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
Grant 9,102,626 - Hecht , et al. August 11, 2
2015-08-11
Multifunctional radical quenchers and their uses
Grant 8,952,025 - Hecht , et al. February 10, 2
2015-02-10
Novel Nicotine Dna Vaccines
App 20150017201 - Chang; Yung ;   et al.
2015-01-15
1H-Pyrrolo [2, 3 -B] Pyridine Derivatives and Their Use as Radical Quenchers
App 20150011580 - Armendariz Guajardo; Jose I. ;   et al.
2015-01-08
Multifunctional Radical Quenchers For The Treatment Of Mitochondrial Dysfunction
App 20140038963 - Hecht; Sidney ;   et al.
2014-02-06
Methods and Compositions for Using Bleomycin-Derivatized Microbubbles
App 20130266518 - Hecht; Sidney ;   et al.
2013-10-10
Multifunctional Radical Quenchers and Their Uses
App 20130267546 - HECHT; Sidney ;   et al.
2013-10-10
Phenazopyridine Compounds
App 20130040917 - HECHT; Sidney ;   et al.
2013-02-14
Phenazopyridine compounds
Grant 8,288,365 - Hecht , et al. October 16, 2
2012-10-16
Carbohydrate-Mediated Tumor Targeting
App 20120148502 - Hecht; Sidney ;   et al.
2012-06-14
Phenazopyridine Compounds
App 20110319367 - Hecht; Sidney ;   et al.
2011-12-29
Methods and Compositions for Using Bleomycin-Derivatized Microbubbles
App 20110293530 - Hecht; Sidney ;   et al.
2011-12-01
Beta-Cyclodextrin Derivatives as Antibacterial Agents
App 20110071108 - Fahmi; Noureddine ;   et al.
2011-03-24
Phenazopyridine compounds
Grant 7,893,042 - Hecht , et al. February 22, 2
2011-02-22
.beta.-Cyclodextrin derivatives
Grant 7,851,457 - Hecht , et al. December 14, 2
2010-12-14
Phenazopyridine Compounds
App 20100204185 - HECHT; Sidney ;   et al.
2010-08-12
.beta.-cyclodextrin derivatives as antibacterial agents
Grant 7,737,132 - Fahmi , et al. June 15, 2
2010-06-15
B-cyclodextrin Derivatives And Their Use Against Anthrax Lethal Toxin
App 20090023210 - KARGINOV; VLADIMIR ;   et al.
2009-01-22
B-cyclodextrin Derivatives And Their Use Against Anthrax Lethal Toxin
App 20090005343 - Hecht; Sidney ;   et al.
2009-01-01
B-cyclodextrin derivatives and their use against anthrax lethal toxin
App 20060247208 - Karginov; Vladimir ;   et al.
2006-11-02
Antibacterial compounds and uses thereof
App 20060235047 - Hecht; Sidney ;   et al.
2006-10-19
Beta-cyclodextrin derivatives as antibacterial agents
App 20060199785 - Fahmi; Noureddine ;   et al.
2006-09-07
Parallel identification of antibacterial targets and inhibitors
App 20060199224 - Schmidt; Frank ;   et al.
2006-09-07
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed